Search results
Results from the WOW.Com Content Network
Certain patients with obstructive sleep apnea who are deemed eligible candidates may be offered the hypoglossal nerve stimulator as an alternative. FDA-approved hypoglossal nerve neurostimulation is considered medically reasonable and necessary for the treatment of moderate to severe obstructive sleep apnea when all of the following criteria are met: [4]
The device, called Portable Neuromodulation Stimulator (PoNS), is a neuromuscular tongue stimulator that consists of a non-implantable apparatus to generate electrical pulses for stimulation of the trigeminal and facial nerves via the tongue to provide treatment of motor deficits. [125]
A transcutaneous electrical nerve stimulation (TENS or TNS) is a device that produces mild electric current to stimulate the nerves for therapeutic purposes.TENS, by definition, covers the complete range of transcutaneously applied currents used for nerve excitation, but the term is often used with a more restrictive intent, namely, to describe the kind of pulses produced by portable ...
The approval opens up a wide market of patients for Lilly at a time when demand for Zepbound is already surging. Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep ...
The Quell wearable device. Quell is a wearable device, manufactured by Neurometrix, that claims to offer relief from chronic pain without the use of drugs. [1] Quell is an FDA approved band worn on the calf and uses Transcutaneous Electrical Nerve Stimulation (TENS) technology.
It is marketed as the only Extracorporeal Shock Wave Technology (ESWT) system approved by the U.S. Food and Drug Administration (FDA) for the treatment of multiple orthopaedic conditions. The OssaTron is currently FDA approved to treat chronic plantar fasciitis (heel pain) and chronic lateral epicondylitis (tennis elbow) when these conditions ...
The injectable drug, branded as Maxigesic IV, was approved as a post-operative drug in hospitals or when patients cannot take medicine orally. Maxigesic IV, a combination of paracetamol with ...
The most common use of SCS is failed back surgery syndrome (FBSS) in the United States and peripheral ischemic pain in Europe. [4] [5]As of 2014 the FDA had approved SCS as a treatment for FBSS, chronic pain, complex regional pain syndrome, intractable angina, as well as visceral abdominal and perineal pain [1] and pain in the extremities from nerve damage.